Terumo India is Great Place to Work®- Certified for the Fourth Time
New Delhi [India], June 23: Terumo India, the Indian arm of global medical technology leader Terumo Corporation (TSE: 4543), has been recognized as a Great Place to Work® for the fourth time, strengthening its position as an employer of choice in the healthcare industry. The certification also reaffirms the company's ongoing commitment to cultivating a culture of trust, respect, and associate well-being, aligned with Terumo's EVP statement of "Advancing Healthcare with Heart."
The Great Place to Work® Certification is a globally respected benchmark for workplace culture. Terumo India's recognition followed a rigorous evaluation process, including anonymous associate feedback, a culture audit of people practices, and in-depth interactions across all levels of the organization. Achieving this certification for the fourth time in a row demonstrates Terumo India's success in consistently creating a work environment where associates thrive and feel valued.
"Securing the Great Place to Work® Certification for the fourth time is a proud moment for all of us at Terumo India. This achievement reflects the collaborative spirit we've nurtured--where every associate feels respected, valued, and empowered. Our people are at the core of our success, and this recognition validates the inclusive and growth-driven culture we've worked tirelessly to build. I'm incredibly proud of our team's dedication and remain committed to ensuring an environment where everyone can thrive and contribute meaningfully to our mission of Contributing to Society through Healthcare," said Shishir Agarwal, President and Managing Director, Terumo India.
Commenting on the achievement Ritu Anand, Vice President - Human Resources and Corporate Communications, Terumo India said "This recognition reflects our continued focus on listening, supporting, and growing together as an organization. At Terumo India, we are deeply guided by our 'Powered by People' philosophy, and we understand that the most successful workplaces are those that offer opportunities for both personal and professional growth. Being certified for the fourth time motivates us to continue fostering a culture where everyone feels a strong sense of belonging and purpose"
This vision of creating a happier, healthier, and inspired workforce continues to guide Terumo India's HR strategy and people-centric approach. As part of its commitment to associate well-being, the company offers a wide range of initiatives from flexible work arrangements and wellness programs to continuous learning and leadership development opportunities. Programs like #TerumoCares provide holistic support to associates, helping them balance both personal and professional responsibilities.
About Terumo India Private Limited
Terumo India is a rapidly growing medical devices company dedicated to advancing access to high-quality cardiac, vascular, and other medical devices for patients and healthcare practitioners in India. As part of Terumo Corporation, a global leader in medical technology headquartered in Tokyo, Japan, Terumo India upholds a mission rooted in 100 years of history: 'Contributing to Society through Healthcare.'
Founded in 2013 and headquartered in Gurgaon, NCR Delhi, Terumo India has touched over 100,000 lives. The company is three times Great Place to Work® certified and was also recognized as one of India's Top 15 Workplaces™ in Pharmaceuticals, Healthcare, and Biotech in 2022. Terumo India also runs several acclaimed training and development programs, collaborating closely with customers and academic partners to address the skilling needs of India's healthcare system.
For more information, visit https://terumoindia.com/
About Terumo
Terumo (TSE: 4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.
For more information, visit https://www.terumo.com/
(ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Wire
10 minutes ago
- The Wire
Heart Valve Replaced Without Surgery Through Arm Artery – First Ever Percutaneous Trans-Axillary TAVI in India
Jaipur – For the first time in India, doctors at Rajasthan Hospital, Jaipur have successfully replaced a heart valve through the artery in the arm without surgery, using a breakthrough technique called Percutaneous Trans-Axillary TAVI. The patient, a 78-year-old man (name changed to Hemendra), had severely blocked arteries in both legs due to calcium buildup, which made the conventional transcatheter valve implantation through the femoral artery impossible. Dr. Ravindra Singh Rao, Vice Chairman of Rajasthan Hospital, and his team performed this innovative and life-saving procedure, claiming it as the first such case in India. Normally, TAVI (Transcatheter Aortic Valve Implantation) is done by passing an artificial valve through the femoral artery in the thigh. However, in Hemendra's case, this route was blocked, and his heart was functioning at only 25% capacity. He also had difficulty breathing, worsening kidney function, and had previously undergone two stent procedures. The Arm Artery: An Alternative Route Refusing to give up, Dr. Rao's team opted for a rare and complex approach. Using ultrasound guidance, they precisely punctured the subclavian artery near the collarbone in the left arm. A small tube (sheath) was inserted, followed by placement of a percutaneous suture system to secure the access point. A larger delivery system was then advanced through the artery, allowing the team to successfully implant the new artificial heart valve. After valve deployment, the artery was sealed using a ProGlide closure device. Until now, the subclavian artery route for TAVI in India was used only through open surgery. This case marks the first ever percutaneous (completely non-surgical) trans-axillary TAVI in the country. A New Life for the Patient The patient's symptoms improved almost immediately after the procedure. His breathing eased, kidney function normalized, and heart efficiency improved significantly. He was discharged from the hospital just five days later, fully stable. A Landmark in Indian Medical History Dr. Ravindra Singh Rao stated, 'In India, around 3–5% of patients suffering from aortic stenosis may have blocked femoral arteries, making the standard TAVI approach unfeasible. For such patients, this alternative arm artery route can be life-saving.' This achievement is not only a milestone for Rajasthan but also a remarkable step forward for Indian cardiology. The success of the percutaneous trans-axillary TAVI has demonstrated that with innovation and courage, even the most complex medical challenges can be overcome. Key Highlights: • First-ever heart valve replacement through the arm artery without surgery in India • Conventional femoral route was blocked due to severe calcification • Patient's heart functioning only at 25%; kidneys also deteriorating • Innovative approach led to full recovery; patient discharged in 5 days • Sets a new path of hope for patients with similar vascular limitations This groundbreaking success showcases the world-class capabilities of Indian interventional cardiology and opens new horizons in minimally invasive heart procedures. Dr Kailash Chandra, Dr Govind Narayan Sharma and Dr Prashant Varshney's support were helpful during procedure. (Disclaimer: The above press release comes to you under an arrangement with NRDPL and PTI takes no editorial responsibility for the same.).
Time of India
15 minutes ago
- Time of India
Tesla opens first showroom in India after years of negotiations marking strategic entry starting with Rs 60 lakh
Source: Tesla Tesla is finally accelerating into India's electric vehicle (EV) market with the launch of its first official showroom in Mumbai. The much-anticipated debut marks a significant step for Elon Musk's company as it tests Indian consumer appetite for premium EVs. The showroom is located at Maker Maxity Mall in Bandra Kurla Complex (BKC) and is set to open on Tuesday morning. This launch comes after years of speculation and signals Tesla's entry into one of the world's fastest-growing automobile markets, albeit cautiously, without local manufacturing, for now. Elon Musk's Tesla debuts in Mumbai embracing retail-first entry strategy Tesla's India debut will be marked by the inauguration of its first showroom at Maker Maxity Mall, a prime location in Mumbai's upscale BKC district as reported by ANI . The company teased the announcement on its India-focused X (formerly Twitter) account last Friday, posting 'Coming soon' with a graphic hinting at a July 2025 launch. This move confirms Tesla's long-anticipated plan to begin operations in India initially via imported models, without committing to local production yet. Despite the buzz, Union Minister for Heavy Industries, H.D. Kumaraswamy, clarified in June that Tesla currently has no plans to manufacture vehicles in India. 'They want to sell their cars in India. There's no further development,' he said during a media interaction. This indicates Tesla is adopting a retail-first strategy, starting with showrooms to gauge demand before making deeper investments like setting up gigafactories or assembly plants. Tesla launches Model Y in India with premium pricing Tesla has officially launched the Model Y in India, with prices starting at Rs 60 lakh, as per the company's updated price catalog released on Tuesday. The electric vehicle giant is offering two variants for Indian buyers: Model Y Rear-Wheel Drive (RWD): Rs 60 lakh Model Y Long Range RWD: Rs 68 lakh These prices apply to outright cash purchases only, as Tesla has not yet introduced any leasing or financing options in the Indian market. When compared globally, the Indian pricing of the Model Y is significantly higher. For reference, the same model starts at $44,990 in the US, 263,500 yuan in China, and €45,970 in Germany. This price gap is largely due to India's steep import duties and associated logistics costs. According to Bloomberg News , five units of the Model Y have already arrived in Mumbai from Tesla's Shanghai plant. These imported vehicles reportedly attracted over Rs 21 lakh in import duties per unit, in line with India's 70% tariff on fully built EVs priced under $40,000. The launch underlines Tesla's retail-first strategy, as the company continues to import vehicles directly while it assesses the Indian market before committing to local manufacturing or assembly. India's revised EV policy could accelerate Tesla's expansion plans Tesla's India plans have historically been hampered by high import duties—a concern Elon Musk has raised multiple times. However, this may soon change. India's newly launched EV policy offers reduced import taxes and attractive incentives for foreign EV manufacturers, potentially smoothing the path for Tesla's expansion. Earlier this year, Tesla also began hiring for roles in India, signaling early operational groundwork. The government's outreach, including Prime Minister Narendra Modi's phone conversation with Elon Musk in April and an earlier meeting during his US visit, hints at growing bilateral cooperation in technology and innovation. What Tesla's launch means for India's EV landscape With the Mumbai showroom launch, Tesla aims to test Indian market readiness for its premium EV lineup, including the Model 3 and Model Y. While price-sensitive Indian buyers may find Tesla's vehicles on the higher end, the brand's arrival adds prestige and momentum to India's growing EV ecosystem. India is already witnessing a surge in electric two-wheelers and budget EVs, but Tesla's entry could redefine consumer expectations in the luxury electric segment, potentially opening doors for competitors like BYD and Mercedes-Benz EQ series to step up their game. While the absence of local manufacturing signals a cautious approach, Tesla's presence in India could be a prelude to larger ambitions. If the new EV policy proves effective, and if demand meets expectations, Tesla might reconsider setting up a manufacturing hub, especially as India offers a large workforce and strategic location for export. Discover everything about the automotive world at Times of India .
Mint
16 minutes ago
- Mint
India bonds yields steady around key levels as RBI to mop up liquidity
MUMBAI, July 15 (Reuters) - Indian government bond yields were largely steady after rising in opening trades on Tuesday, as traders cool their heels around key levels, and eye the response to the central bank's liquidity withdrawal operation. The yield on the benchmark 10-year bond was at 6.3173% as of 10:00 a.m. IST after closing at 6.3163% on Monday. The Reserve Bank of India will conduct a three-day variable rate reverse repo auction for 1 trillion rupees ($11.6 billion). This would be in addition to 1.52 trillion rupees that it withdrew from the banking system on Friday via a seven-day operation. This is the second straight week that the RBI is conducting a shorter duration cash withdrawal operation, after doing a seven-day equivalent. "The market will start absorbing such reverse repos and will not react much going ahead, like we are seeing today," a trader with a private bank said. India's weighted average interbank call money rate as well as weighted average tri-party repo rate eased on Monday, with the latter moving below the RBI's standing deposit facility rate of 5.25%. The facility acts as a floor for the monetary policy corridor. Meanwhile, India's annual retail inflation slowed to a more than six-year low of 2.10% in June, lower than the 2.5% estimated by economists in a Reuters poll and the 2.82% reading in May. This has led to economists trimming down their full-year inflation forecasts and expecting at least one more rate cut. Core inflation, which excludes volatile items such as food and energy and is an indicator of domestic demand, however, accelerated to 4.4%-4.5% in June, from 4.17%-4.20% in May, according to economists. India's overnight index swap rates were little changed with traders awaiting U.S. inflation data. The one-year OIS rate was at 5.54% and the two-year OIS rate was at 5.53%. The liquid five-year was at 5.71%. ($1 = 85.9290 Indian rupees) (Reporting by Dharamraj Dhutia)
